Government Plans to Redevelop Idle Land of Closed Pharma PSUs for Healthcare & Education

In a strategic move to optimise underutilised public assets, the Indian government is charting out a redevelopment plan for the idle land holdings of closed pharmaceutical PSUs, including Indian Drugs and Pharmaceuticals Limited (IDPL) and Bengal Immunity Limited.

Transforming Idle State Assets for Public Benefit

The initiative aims to repurpose these lands for educational and research institutions, particularly in medical sciences and healthcare. According to an official source, the government believes that leveraging these assets for research and education would be the most productive approach, given the growing need for healthcare innovation and talent development.

“The government’s plan reflects a strategic push to repurpose idle state assets for productive use. It would be better if we go for education and research purposes, as the medical science or healthcare value chain requires that more than anything,” an official told Moneycontrol.

A major breakthrough for the redevelopment process came with a favourable order from the National Company Law Tribunal (NCLT) on January 7, which removed long-standing legal obstacles that had been delaying the repurposing of these lands.

“It is a very major gain for the department. If there is something good which contributes to the healthcare value chain, it should be pursued,” the official added.

Aligning with India’s Broader Policy Goals

The government’s decision to repurpose these assets for healthcare and education is in line with its broader policy goals of:

  1. Optimising underutilised state-owned properties
  2. Strengthening India’s healthcare ecosystem
  3. Enhancing medical research and innovation
  4. Bridging the gap in medical education and training

With India’s expanding healthcare needs and a push for self-reliance in pharmaceuticals and medical research, this initiative is expected to play a crucial role in bolstering India’s healthcare and education infrastructure.

Sneha Gandhi

Sneha Gandhi is a passionate stock market learner and finance content writer who loves exploring market trends and sharing the latest updates with readers. She enjoys simplifying complex market news and making financial insights easy for everyone to understand.

Published by
Sneha Gandhi

Recent Posts

Why Ramesh Damani Says Gold Can’t Beat the Sensex in the Long Run

Gold Versus Sensex in the Long Run? Ramesh Damani Calls the Comparison ‘Nonsense’ As gold…

18 hours ago

Wall Street Closes Lower as Tech Sell-Off Pushes Nasdaq to Lowest Since November

Wall Street Slides as Tech Sell-Off Drags Nasdaq to Its Lowest Level Since November US…

18 hours ago

KEC International Wins Record India T&D Contract, Bags Rs.1,150 Crore Orders

KEC International Secures ₹1,150 Crore in New Orders, Lands Largest-Ever India T&D Contract KEC International…

19 hours ago

SAIL’s Performance Improves With 14% Growth in April–November 2025

SAIL Delivers 14% Sales Growth in April–November 2025, Showing Resilience Amid Global Steel Headwinds Steel…

19 hours ago

IndiGo Approves Rs 500 Crore Payout for Passengers Impacted by Flight Disruptions

IndiGo Estimates Over ₹500 Crore Payout as Airline Moves to Compensate Passengers Hit by December…

19 hours ago

How 35-Year-Old Parents Should Weigh PPF Against Fixed Deposits in 2025

PPF vs Fixed Deposit in 2025: What a 35-Year-Old With Kids Should Choose for Safer…

19 hours ago

This website uses cookies.